IMCAS Exclusive Interview, recorded during IMCAS World Congress 2025.
"The number one fear of these patients is actually not the economic fear of, 'How much will this cost me?' It's not time commitment. It's, 'Will you make me look like I gained weight?'"
How do top clinicians manage the challenges of GLP-1 therapy while supporting patients’ overall health and appearance? Join us for a conversation with Dr. Suzanne Kilmer, Dr. Orit Markowitz, and Dr. Andreas Nikolis to find the answers practitioners are seeking. Together, they share their experiences treating patients on or after GLP-1 therapy, focusing on how to address secondary symptoms and regain the volume and elasticity needed to restore more youthful appearances post weight loss.
Dr. Kilmer, Dr. Markowitz, and Dr. Nikolis share their strategies for handling significant volume loss and skin laxity and reveal the ultimate obstacle can be the patients themselves. Listen as they discuss the real-world complexities of GLP-1 treatment, the lessons learned along the way, and the approaches that are providing promising results. Whether you’re a clinician or someone curious about the impact of GLP-1 on patient care, this conversation offers rare insights and actionable guidance.
The study referenced by Dr. Andreas Nikolas can be found here.
Consensus Statements on Managing Aesthetic Needs in Prescription Medication‐Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study, published in March 2025, authored by Andreas Nikolas, Kaitlyn Enright, Sabrina G Fabi, Michael Somenek, Hugues Cartier, Luiz Avelar, Johnny Franco, Alessandra Haddad, Maria Magdalini Khattar, Jeff Huang, Tyler Safran, Inna Prygova, Steven Dyan.
